www.bna.com Mergers & Acquisitions Law Report
HomeIndexTable of CasesFeedbackwww.bna.com

Printable version (PDF) 

INDEX
Vol. 13, Nos. 1-49 pp. 1-1196
Jan. 4 -- December 20, 2010

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

    HEALTH CARE
      – Accounting, net revenue and doubtful accounts, FASB approves disclosure proposal, 1085
      – Alcan medical packaging unit, Amcor acquisition approved subject to divestitures, 573
      – Antitrust
      – Attorney-client privilege re disclosure of qui tam suit, analysis, 1097
      – Bankruptcy
        – – Medical Staffing Network Holding, asset purchase agreement announced (Bankr. S.D. Fla.), 701
        – – Technology firm Spheris files for Ch. 11 protection, Medquist and CBay stalking horses, 156
      – Biotechnology industry
        – – Investments decline, 388
        – – Life sciences companies, health reform bill to increase acquisition planning due diligence, 508
        – – Regenerative medicine financing scarce, 971
      – Blue Cross Blue Shield of Mich.
        – – Insurance company acquisitions upheld, contributions may have violated charter (Mich. Ct. App.), 1164
        – – Sparrow's Physician Health Plan merger called off, 241
      – Cardinal Health to purchase pharmaceutical services entity, 587
      – Carilion Clinic sale of Center of Surgical Excellence approved by FTC, 313
      – Caritas Christi Health Care purchase by equity fund under review by state, 323; state IG approves, 944
      – Class action, antitrust claims against health system fails common questions of law and fact requirements (N.D. Ill.), 387
      – Dartmouth-Hitchcock acquisition of Catholic Medical Center Healthcare Sys. opposed by N.H. AG, 535
      – Drug companies
      – Genetic testing, Genzyme sells unit to LabCorp, 1191
      – Hospitals
      – Humana to purchase Concentra chain, 1127
      – IMS Health drug information and consulting firm acquisition by investment firms, EC clears, 155
      – Industry performance expected to increase, 61
      – Information technology
      – Lifespan and Care New England merger application withdrawn, 241
      – Market domination by top insurers hampers competition, 232
      – Medical devices
        – – Cardiac devices, St. Jude Medical to buy AGA, 971
        – – Covidien, ev3 buyout to increase cardiovascular market, 587
        – – Disposable hygiene products manufacturer, Ontex joint control by Goldman Sachs and TPG Group, EC clears, 927
        – – FTC annual report cites blocked mergers, 419
        – – Hernia repair products, successor liability for preacqusition claims (8th Cir.), 871
        – – Johnson & Johnson amended complaint over failed Guidant deal subject to res judicata (S.D.N.Y.), 196
        – – Laser microdissection, Danaher/MDS Analytical Technologies merger, FTC requires divestiture (FTC), 118
        – – ObTape litigation, successor liability may follow merger (N.D. Ga.), 873
        – – Orthopedic devices, Stryker to acquire Boston Scientific neurovascular division, 1014
      – Medical products, Reckitt Benckiser/SSL Intl. merger, EC approves approved subject to divestitures, 987
      – Medicare reimbursements, depreciable assets disallowed (D.C. Cir.), 675
      – MediConnect Global acquires PassportMD, 64
      – Nursing homes, ownership transparency, GAO report, 992
      – PacifiCare, Calif. to fine for health claims processing violations, 906
      – PacificSource Health announces acquisition of Clear One Health Plans, 62
      – PeaceHealth and Southwest Washington Health Systems of Wash. discuss merger, 323
      – Pharmacies, health information misuse, CVS/Caremark merger
        – – FTC urged to reopen investigation, 1021
        – – Retailers allege HIPAA violations (S.D. Tex.), 944
      – Premerger notifications, DOJ/FTC annual report, 955
      – Protective equipment, Honeywell bid for Sperian, EC approves, 743
      – Retiree benefits
        – – Benefits book deemed summary plan description modifying active and retiree parity requirement (E.D. La.), 1056
        – – Oral misrepresentations, ERISA imposes affirmative duty to disclose right to change plan benefits (U.S., rev den), 202
      – Taxation, settlement payments and litigation costs defending for-profit's use of charitable assets required to be capitalized (7th Cir.), 319
      – Tenn. merger notification requirements apply to subsidiary mergers, 387
      – UnitedHealthcare purchase of Health Net assets, Conn. medical society urges probe for possible HIPAA privacy violations, 137
      – Walgreens purchases Duane Reade of N.Y., 209
    HEDGE FUNDS
      – EU, regs. advance, 481; becomes law, 1091
      – Galleon fund
      – Insider trading
      – Investment fund advisor registration, SEC Prop. Regs., 1111; enforcement priorities being identified, 1113
      – NACCO/Applica failed merger, fraud claims to proceed (Del. Ch.), 9
    HEDGES
      – Bank restrictions
        See LEGISLATION, FEDERAL, HR 4173
      – Loss treatment of insurance payments on expiration (CCA), 579
      – Regulatory oversight
        See LEGISLATION, FEDERAL, S 3217
      – Strategic equity investments, IASB rules out separate model, 808
    HOSPITALS
      – Antitrust
        – – ProMedica Health Systems, St. Luke's and Paramount Health Care merger, FTC seeks court order to force production of documents (N.D. Ohio), 957
        – – Scott & White Healthcare/King's Daughter Hospital merger, FTC closes investigation, 6
        – – Universal Health Services acquisition of Psychiatric Solutions, divestment of psychiatric facilities required (FTC), 1069
      – Caritas Christi HealthCare purchase by equity fund under review by state, 323; state IG approves, 944
      – Harrisburg Hospital/Seidle Memorial and Polyclinic Medical Center merger not bona fide sale (D.D.C.), 632
      – Merger advice consultants, broker-dealer registration requirements, SEC staff declines relief (SEC), 1143
      – Physician practice acquisitions, pitfalls, 632
      – Sale, disparity between price and asset value not bona fide sale (E.D. Pa.), 929
      – Tenn. merger notification requirements apply to subsidiary mergers, 387
    HOSTILE TAKEOVERS
      – Takeover defenses, shareholder rights/poison pill plans
      – U.K. Takeover Panel proposes restrictions, 965

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.